[Migraine, serotonin and serotonergic receptors].
Pascual
J
J
Departamento de Medicina y Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander.
D001812:Blood-Brain Barrier / Q000187:drug effects; D005260:Female; D006801:Humans; D007650:Ketanserin / Q000378:metabolism / Q000627:therapeutic use; D008125:Locus Coeruleus / Q000187:drug effects; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000517:prevention & control; D011433:Propranolol / Q000378:metabolism / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000378:metabolism* / Q000502:physiology; D012701:Serotonin / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D009435:Synaptic Transmission / Q000187:drug effects
D007650:Ketanserin; D011433:Propranolol; D011985:Receptors, Serotonin; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors